Ana Izquierdo Gil

Instituto de Investigación Nutricional — PE

Medicine · Health Sciences

8h-index354citations16works2.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

SARS-CoV-2 and COVID-19 Research(7), COVID-19 Clinical Research Studies(5), Respiratory viral infections research(4), Viral Infections and Outbreaks Research(4), SARS-CoV-2 detection and testing(3)

Publications16 total

Declines in Human Rhinovirus, Coronavirus, Parainfluenza, and Adenovirus Infections During the COVID‐19 Pandemic: Evidence From Household‐Based Cohort Studies in Lima, Peru
Influenza and Other Respiratory Viruses·2026Open Access
Plant Cell Culture-Derived Saponin Adjuvant Enhances Immune Response Against a Stabilized Human Metapneumovirus Pre-Fusion Vaccine Candidate
Vaccines·2024· 6 citedOpen Access
Systems Biology-Based Assessment of Immune Responses to Whole Cell and Acellular Pertussis Vaccines: Rationale, Methodology and Enrollment Procedures for Omics Workflows
2024Open Access
Enhancing breadth and durability of humoral immune responses in non-human primates with an adjuvanted group 1 influenza hemagglutinin stem antigen
npj Vaccines·2023· 6 citedOpen Access
Booster vaccination with Ad26.COV2.S or an Omicron-adapted vaccine in pre-immune hamsters protects against Omicron BA.2
npj Vaccines·2023· 5 citedOpen Access
Sequential use of Ad26-based vaccine regimens in NHP to induce immunity against different disease targets
npj Vaccines·2022· 7 citedOpen Access
Immunogenicity of an Ad26-based SARS-CoV-2 Omicron Vaccine in Naïve Mice and SARS-CoV-2 Spike Pre-immune Hamsters
2022· 2 citedOpen Access
Immunogenicity and efficacy of one and two doses of Ad26.COV2.S COVID vaccine in adult and aged NHP
The Journal of Experimental Medicine·2021· 69 citedOpen Access
Ad26.COV2.S protects Syrian hamsters against G614 spike variant SARS-CoV-2 and does not enhance respiratory disease
npj Vaccines·2021· 47 citedOpen Access
Ad26.COV2.S-elicited immunity protects against G614 spike variant SARS-CoV-2 infection in Syrian hamsters and does not enhance respiratory disease in challenged animals with breakthrough infection after sub-optimal vaccine dosing
2021· 4 cited
Immunogenicity and protective efficacy of one- and two-dose regimens of the Ad26.COV2.S COVID-19 vaccine candidate in adult and aged rhesus macaques
2020· 10 citedOpen Access
Adenovectors encoding RSV-F protein induce durable and mucosal immunity in macaques after two intramuscular administrations
npj Vaccines·2019· 32 citedOpen Access
Immunogenicity and Safety of Yellow Fever Vaccine (Stamaril) When Administered Concomitantly With a Tetravalent Dengue Vaccine Candidate in Healthy Toddlers at 12–13 Months of Age in Colombia and Peru
The Pediatric Infectious Disease Journal·2016· 27 cited
Immunogenicity and safety of tetravalent dengue vaccine in 2–11 year-olds previously vaccinated against yellow fever: Randomized, controlled, phase II study in Piura, Peru
Vaccine·2012· 70 cited
Safety and Immunogenicity of an Investigational Fully Liquid Hexavalent DTaP-IPV-Hep B-PRP-T Vaccine at Two, Four and Six Months of Age Compared With Licensed Vaccines in Latin America
The Pediatric Infectious Disease Journal·2012· 35 cited
Interference assessment of yellow fever vaccine with the immune response to a single-dose inactivated hepatitis A vaccine (1440 EL.U.). A controlled study in adults
Vaccine·1996· 34 cited

Frequent Co-authors

Roland Zahn(10), Hanneke Schuitemaker(9), Leacky Muchene(7), Jeroen Tolboom(7), Harmjan Kuipers(6), Ying Choi(6), Frank Wegmann(6), Liesbeth Dekking(5), Ella van Huizen(5), Jessica Vreugdenhil(5), Marjolein van Heerden(5), Ramon Roozendaal(5), Claudio F. Lanata(4), Sietske K. Rosendahl Huber(4), Joan E. M. van der Lubbe(4), Miranda R.M. Baert(4), Eleni Kourkouta(4), Jerome Custers(4), Tim J. Dalebout(4), Sebenzile K. Myeni(4)